Xenon Pharmaceuticals (XENE) Restructuring Costs (2024 - 2026)
Xenon Pharmaceuticals (XENE) posted quarterly Restructuring Costs of $7.8 million for Q1 2026, up 41.04% year-over-year from $5.5 million in Q1 2025, and down 8.59% quarter-over-quarter from $8.5 million in Q4 2025.
Xenon Pharmaceuticals (XENE) Restructuring Costs (2024 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported Restructuring Costs for 3 consecutive years, with $7.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Restructuring Costs rose 41.04% year-over-year to $7.8 million; the TTM figure through Mar 2026 stood at $29.1 million (up 36.52% YoY), while the FY2025 annual figure was $26.8 million, up 29.71% from the prior year.
- Restructuring Costs slipped to $7.8 million in Q1 2026 per XENE's latest filing, from $8.5 million in the prior quarter.
- Across five years, Restructuring Costs topped out at $8.5 million in Q4 2025 and bottomed at $4.6 million in Q3 2024.
- Historically, Restructuring Costs has averaged $6.1 million across 3 years, with a median of $5.7 million in 2024.
- On a YoY basis, Restructuring Costs climbed as much as 53.99% in 2025 and fell as far as 6.27% in 2025.
- Xenon Pharmaceuticals' Restructuring Costs stood at $5.5 million in 2024, then jumped by 53.99% to $8.5 million in 2025, then fell by 8.59% to $7.8 million in 2026.
- Business Quant data shows XENE's Restructuring Costs at $7.8 million in Q1 2026, $8.5 million in Q4 2025, and $6.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Xenon Pharmaceuticals | 6.03 Bn | 6.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.03 Mn |
| Mar 31, 2026 | 7.80 Mn |
| Dec 31, 2025 | 8.53 Mn |
| Sep 30, 2025 | 6.72 Mn |
| Jun 30, 2025 | 6.01 Mn |
| Mar 31, 2025 | 5.53 Mn |
| Dec 31, 2024 | 5.54 Mn |
| Sep 30, 2024 | 4.56 Mn |
| Jun 30, 2024 | 5.66 Mn |
| Mar 31, 2024 | 4.90 Mn |